AGP Picks
View all

Health Review Macao: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Review Macao.

Press releases published on October 20, 2026

BioNTech veröffentlicht am 3. November 2026 Ergebnisse für das dritte Quartal 2026 und informiert über operativen Fortschritt
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study
Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania
Maxion Therapeutics Appoints Biopharma Leader Mikael Dolsten to Board of Directors
Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week 2026
KFSH Brings Cardiac Catheterization Directly to Emergency Department to Accelerate Critical Care
Aqua free erweitert Produktportfolio: Neuer Baclyser® neo T Max für noch mehr Kapazität und Effizienz
Aqua free expands its product portfolio: New Baclyser® neo T Max offers greater capacity and efficiency
Aqua free élargit sa gamme de produits : le nouveau Baclyser® neo T Max pour une capacité et une efficacité accrues
Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch
Mestag Therapeutics Appoints Philip Astley-Sparke and Victor Sandor, M.D.C.M., to its Board of Directors
Gesynta Pharma completes enrollment in Phase 2 NOVA trial evaluating vipoglanstat in endometriosis
AltruBio Presents Phase 2a Data of ALTB-268 in Advanced Therapy-Refractory Ulcerative Colitis at UEG Week 2026
Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting
Ambrose Healthcare Acquires AM-Pharma for Up to €161 Million, Expanding its Rare Disease Pipeline and Gaining a European Base
Calcium-rich whey permeate improves bone health in postmenopausal women, study finds
Basilea gibt Präsentation neuer Daten zu Fosmanogepix, Isavuconazol und Ceftobiprol auf der IDWeek 2026 bekannt
Basilea reports presentation of new data for fosmanogepix, isavuconazole and ceftobiprole at IDWeek 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Review Macao

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.